ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

UK Research Groups To Fund Virtual Tumor Bank

April 18, 2003

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006